Capillary Technologies' GMP was showing a modest profit, but the company delivered a b market listing on November 21. The share's entry proved beneficial for investors. The listing price was favorable, and the current price remains b.
IPO Update: Capillary Technologies India's listing did not provide investors with the expected benefits. As soon as the market opened, the share listed at a discount, leaving investors surprised. Many investors stated that the GMP had indicated a modest profit, but the listing diminished their expectations. The company's share entered the market on Friday, November 21, and after the listing, investors wondered what direction the share would take next.
At what price did the share list?
The company's issue price was fixed at Rs 577 per share. However, the share listed at Rs 571.90. This means investors incurred a loss of approximately Rs 5.10 per share, which is a decline of about 1 percent. Immediately after the listing, many investors appeared troubled by this weakness and concerned about their future strategy.
Price Band Information
For Capillary Technologies' IPO, the company had set a price band of Rs 549 to Rs 577. This price band was considered high-value, which led investors to expect better performance at the time of listing. However, the weak listing diminished this expectation.
Issue Price and Lot Size
To purchase the IPO, investors paid Rs 577 per share. One lot consisted of 25 equity shares, meaning investors had to pay Rs 14,425 for one lot. Many investors had invested in more than one lot, so the listing at a discount resulted in losses for all of them.
Total IPO Issue Size
The company issued a fresh issue worth Rs 34,500 lakh through the IPO. Additionally, 9,228,796 shares were sold under the Offer for Sale (OFS). In the OFS, shares worth Rs 2 crore were reserved for employees, while 6,828,001 shares were allocated for anchor investors. Despite the large issue size, investor response to the listing appeared weak.
